Tokyo Tape
Sign in
← Otsuka Holdings

Quarterly report · Q2

4578.TEDINET S100RHW0
Period2023-01-01 → 2023-06-30
Filed2023-07-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥947.5bn2023-01-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥499.2bn2023-04-01 → 2023-06-30dCons.Revenue IFRS
Revenue¥1.74T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥814.3bn2022-01-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥434.0bn2022-04-01 → 2022-06-30dCons.Revenue IFRS
Operating income¥130.7bn2023-01-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥53.9bn2023-04-01 → 2023-06-30dCons.Operating profit loss IFRS
Operating income¥67.1bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥46.4bn2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Profit before tax¥138.8bn2023-01-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥59.6bn2023-04-01 → 2023-06-30dCons.Profit loss before tax IFRS
Profit before tax¥173.0bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥92.8bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥61.8bn2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Net income (owners)¥102.6bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.2bn2023-04-01 → 2023-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥133.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥69.8bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥46.5bn2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥105.1bn2023-01-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥42.4bn2023-04-01 → 2023-06-30dCons.Profit loss IFRS
Net income¥71.5bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥47.3bn2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Total assets¥3.31Tat 2023-06-30Cons.Assets IFRS
Total assets¥3.10Tat 2022-12-31Cons.Assets IFRS
Total assets¥3.10Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥840.3bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥840.3bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥2.47Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥2.26Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.26Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥2.05Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥2.43Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.23Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.23Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥498.7bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥471.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥456.8bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥410.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥113.5bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥211.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥118.8bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥54.3bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.6bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥56.0bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥46.8bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥95.5bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥48.2bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥189.062023-01-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥75.852023-04-01 → 2023-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥246.82022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥128.612022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥85.742022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥189.062023-01-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥75.852023-04-01 → 2023-06-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥246.782022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥128.572022-01-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥85.692022-04-01 → 2022-06-30dCons.Diluted earnings loss per share IFRS
Equity ratio73.4%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.7%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.8%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-06-30¥87.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥44.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-06-30¥66.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥33.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-06-30¥21.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥11.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-06-30¥7.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30¥4.0bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥21.1bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥11.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥21.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥11.5bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥25.3bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥12.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2023-01-01 → 2023-06-30¥17.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥9.2bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2023-01-01 → 2023-06-30¥17.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥9.2bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥9m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥4m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2023-01-01 → 2023-06-30¥8.0bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥5.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥226.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2023-04-01 → 2023-06-30¥122.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥226.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-04-01 → 2023-06-30¥122.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥54m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥40m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥6.7bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-04-01 → 2023-06-30−¥4.5bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥637.9bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-04-01 → 2023-06-30¥334.7bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥637.9bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-04-01 → 2023-06-30¥334.7bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥133.6bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-04-01 → 2023-06-30¥61.0bn
—segment totalrevenue2023-01-01 → 2023-06-30¥968.7bn
—segment totalrevenue2023-04-01 → 2023-06-30¥510.7bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥947.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥499.2bn
—segment totalrevenue intersegment2023-01-01 → 2023-06-30¥21.1bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥11.5bn
—segment totalsegment profit2023-01-01 → 2023-06-30¥156.0bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥66.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-06-30¥82.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥43.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-06-30¥62.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥32.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-06-30¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥11.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-06-30¥7.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥3.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥20.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥11.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥20.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥11.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥22.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥11.1bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2022-01-01 → 2022-06-30¥16.7bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥9.0bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2022-01-01 → 2022-06-30¥16.7bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥9.0bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.8bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2022-01-01 → 2022-06-30¥205.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2022-04-01 → 2022-06-30¥115.4bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-01-01 → 2022-06-30¥205.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥115.4bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥11m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥7m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-01-01 → 2022-06-30¥28.1bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥16.9bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-06-30¥529.3bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-04-01 → 2022-06-30¥277.2bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-06-30¥529.3bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥277.2bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-06-30¥52.2bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥34.9bn
—segment totalrevenue2022-01-01 → 2022-06-30¥834.4bn
—segment totalrevenue2022-04-01 → 2022-06-30¥445.3bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥814.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥434.0bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥20.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥11.3bn
—segment totalsegment profit2022-01-01 → 2022-06-30¥90.0bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥57.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 894
ItemContextValueUnit
Impairment losses pl IFRSCurrentYTDDuration28929000000JPY
Other income IFRSPrior1YTDDuration13890000000JPY
Other income IFRSCurrentYTDDuration5580000000JPY
Other expenses IFRSPrior1YTDDuration514000000JPY
Other expenses IFRSCurrentYTDDuration1006000000JPY
Operating profit loss IFRSPrior1YTDDuration67146000000JPY
Operating profit loss IFRSCurrentYTDDuration130690000000JPY
Finance income IFRSPrior1YTDDuration28175000000JPY
Finance income IFRSCurrentYTDDuration10538000000JPY
Finance costs IFRSPrior1YTDDuration2532000000JPY
Finance costs IFRSCurrentYTDDuration2395000000JPY
Profit loss before tax IFRSPrior1YTDDuration92788000000JPY
Profit loss before tax IFRSCurrentYTDDuration138833000000JPY
Income tax expense IFRSPrior1YTDDuration21264000000JPY
Income tax expense IFRSCurrentYTDDuration33774000000JPY
Profit loss IFRSPrior1YTDDuration71524000000JPY
Profit loss IFRSCurrentYTDDuration105058000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration69770000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration102594000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration1753000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration2464000000JPY
Profit loss IFRSPrior1YTDDuration71524000000JPY
Profit loss IFRSCurrentYTDDuration105058000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration128.61
Basic earnings loss per share IFRSCurrentYTDDuration189.06
Diluted earnings loss per share IFRSPrior1YTDDuration128.57
Diluted earnings loss per share IFRSCurrentYTDDuration189.06
Revenue IFRSPrior1QuarterDuration433998000000JPY
Revenue IFRSCurrentQuarterDuration499193000000JPY
Cost of sales IFRSPrior1QuarterDuration147947000000JPY
Cost of sales IFRSCurrentQuarterDuration151086000000JPY
Gross profit IFRSPrior1QuarterDuration286051000000JPY
Gross profit IFRSCurrentQuarterDuration348106000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration184905000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration196725000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration373000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration4119000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration65861000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration74134000000JPY
Impairment losses pl IFRSPrior1QuarterDuration524000000JPY
Impairment losses pl IFRSCurrentQuarterDuration28718000000JPY
Other income IFRSPrior1QuarterDuration11531000000JPY
Other income IFRSCurrentQuarterDuration1731000000JPY
Other expenses IFRSPrior1QuarterDuration268000000JPY
Other expenses IFRSCurrentQuarterDuration467000000JPY
Operating profit loss IFRSPrior1QuarterDuration46396000000JPY
Operating profit loss IFRSCurrentQuarterDuration53911000000JPY
Finance income IFRSPrior1QuarterDuration17024000000JPY
Finance income IFRSCurrentQuarterDuration6868000000JPY
Finance costs IFRSPrior1QuarterDuration1617000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass